KFDA calls for tighter bioequivalence testing

The Korea Food and Drug Administration (KFDA) has recently called on local pharmaceutical companies to conduct their own bioequivalence testing to raise their transparency.

In a press interview, a senior KFDA official said it will abolish the consignment bioequivalence testing early next year, as many generic drugs with identical ingredients have been rampant on the market without restrictio...